Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells

Nature volume 460, pages 53–59 (2009)Cite this article

Abstract

The generation of induced pluripotent stem (iPS) cells has enabled the derivation of patient-specific pluripotent cells and provided valuable experimental platforms to model human disease. Patient-specific iPS cells are also thought to hold great therapeutic potential, although direct evidence for this is still lacking. Here we show that, on correction of the genetic defect, somatic cells from Fanconi anaemia patients can be reprogrammed to pluripotency to generate patient-specific iPS cells. These cell lines appear indistinguishable from human embryonic stem cells and iPS cells from healthy individuals. Most importantly, we show that corrected Fanconi-anaemia-specific iPS cells can give rise to haematopoietic progenitors of the myeloid and erythroid lineages that are phenotypically normal, that is, disease-free. These data offer proof-of-concept that iPS cell technology can be used for the generation of disease-corrected, patient-specific cells with potential value for cell therapy applications.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Derivation of patient-specific induced pluripotent stem cells from Fanconi anaemia patients.
Figure 2: Molecular characterization of FA-iPS cell lines.
Figure 3: Pluripotency of FA-iPS cells.
Figure 4: Functional FA pathway in FA-iPS cells.
Figure 5: Generation of disease-free haematopoietic progenitors from FA-iPS cell lines.

Similar content being viewed by others

References

  1. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006)

    Article  CAS  Google Scholar 

  2. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007)

    Article  CAS  Google Scholar 

  3. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007)

    Article  ADS  CAS  Google Scholar 

  4. Park, I. H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141–146 (2008)

    Article  ADS  CAS  Google Scholar 

  5. Lowry, W. E. et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl Acad. Sci. USA 105, 2883–2888 (2008)

    Article  ADS  CAS  Google Scholar 

  6. Park, I. H. et al. Disease-specific induced pluripotent stem cells. Cell 134, 877–886 (2008)

    Article  CAS  Google Scholar 

  7. Dimos, J. T. et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218–1221 (2008)

    Article  ADS  CAS  Google Scholar 

  8. Ebert, A. D. et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277–280 (2009)

    Article  ADS  CAS  Google Scholar 

  9. Soldner, F. et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964–977 (2009)

    Article  CAS  Google Scholar 

  10. Tischkowitz, M. D. & Hodgson, S. V. Fanconi anaemia. J. Med. Genet. 40, 1–10 (2003)

    Article  CAS  Google Scholar 

  11. Wang, W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nature Rev. Genet. 8, 735–748 (2007)

    Article  CAS  Google Scholar 

  12. Auerbach, A. D. & Wolman, S. R. Susceptibility of Fanconi’s anaemia fibroblasts to chromosome damage by carcinogens. Nature 261, 494–496 (1976)

    Article  ADS  CAS  Google Scholar 

  13. Kutler, D. I. et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101, 1249–1256 (2003)

    Article  CAS  Google Scholar 

  14. Guardiola, P. et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 95, 422–429 (2000)

    CAS  PubMed  Google Scholar 

  15. Wagner, J. E. et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 109, 2256–2262 (2007)

    Article  CAS  Google Scholar 

  16. Waisfisz, Q. et al. Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nature Genet. 22, 379–383 (1999)

    Article  CAS  Google Scholar 

  17. Gregory, J. J. et al. Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells. Proc. Natl Acad. Sci. USA 98, 2532–2537 (2001)

    Article  ADS  CAS  Google Scholar 

  18. Gross, M. et al. Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction. Cytogenet. Genome Res. 98, 126–135 (2002)

    Article  CAS  Google Scholar 

  19. Rio, P. et al. In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1. Blood 112, 4853–4861 (2008)

    Article  CAS  Google Scholar 

  20. Liu, J. M. et al. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Hum. Gene Ther. 10, 2337–2346 (1999)

    Article  CAS  Google Scholar 

  21. Kelly, P. F. et al. Stem cell collection and gene transfer in Fanconi anemia. Mol. Ther. 15, 211–219 (2007)

    Article  CAS  Google Scholar 

  22. Larghero, J. et al. Hematopoietic progenitor cell harvest and functionality in Fanconi anemia patients. Blood 100, 3051 (2002)

    Article  CAS  Google Scholar 

  23. Jacome, A. et al. Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients. Mol. Ther (in the press)

  24. Ying, Q. L. et al. The ground state of embryonic stem cell self-renewal. Nature 453, 519–523 (2008)

    Article  ADS  CAS  Google Scholar 

  25. Taniguchi, T. & D’Andrea, A. D. Molecular pathogenesis of Fanconi anemia: recent progress. Blood 107, 4223–4233 (2006)

    Article  CAS  Google Scholar 

  26. Almarza, E. et al. Characteristics of lentiviral vectors harboring the proximal promoter of the vav proto-oncogene: a weak and efficient promoter for gene therapy. Mol. Ther. 15, 1487–1494 (2007)

    Article  CAS  Google Scholar 

  27. Aasen, T. et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nature Biotechnol. 26, 1276–1284 (2008)

    Article  CAS  Google Scholar 

  28. Kalb, R. et al. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. Am. J. Hum. Genet. 80, 895–910 (2007)

    Article  CAS  Google Scholar 

  29. Brivanlou, A. H. et al. Stem cells. Setting standards for human embryonic stem cells. Science 300, 913–916 (2003)

    Article  CAS  Google Scholar 

  30. Raya, A. et al. Generation of cardiomyocytes from new human embryonic stem cell lines derived from poor-quality blastocysts. Cold Spring Harb. Symp. Quant. Biol. (in the press)

  31. Pfeifer, A., Ikawa, M., Dayn, Y. & Verma, I. M. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc. Natl Acad. Sci. USA 99, 2140–2145 (2002)

    Article  ADS  CAS  Google Scholar 

  32. Xia, X., Zhang, Y., Zieth, C. R. & Zhang, S. C. Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner. Stem Cells Dev. 16, 167–176 (2007)

    Article  CAS  Google Scholar 

  33. Bogliolo, M. et al. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J. 26, 1340–1351 (2007)

    Article  CAS  Google Scholar 

  34. Nakano, T., Kodama, H. & Honjo, T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 265, 1098–1101 (1994)

    Article  ADS  CAS  Google Scholar 

  35. Vodyanik, M. A., Bork, J. A., Thomson, J. A. & Slukvin, I. I. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 105, 617–626 (2005)

    Article  CAS  Google Scholar 

  36. Ji, J., Vijayaragavan, K., Bosse, M., Weisel, K. & Bhatia, M. OP9 stroma augments survival of hematopoietic precursors and progenitors during hematopoietic differentiation from human embryonic stem cells. Stem Cells 26, 2485–2495 (2008)

    Article  CAS  Google Scholar 

  37. Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313–317 (2007)

    Article  ADS  CAS  Google Scholar 

  38. Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnol. 26, 101–106 (2008)

    Article  CAS  Google Scholar 

  39. Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. & Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949–953 (2008)

    Article  ADS  CAS  Google Scholar 

  40. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. & Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science 322, 945–949 (2008)

    Article  ADS  CAS  Google Scholar 

  41. Zhou, H. et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381–384 (2009)

    Article  CAS  Google Scholar 

  42. Gonzalez, F. et al. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc. Natl Acad. Sci. USA 10.1073/pnas.0901471106 (2009)

  43. Hacein-Bey-Abina, S. et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118, 3132–3142 (2008)

    Article  CAS  Google Scholar 

  44. Zwaka, T. P. & Thomson, J. A. Homologous recombination in human embryonic stem cells. Nature Biotechnol. 21, 319–321 (2003)

    Article  CAS  Google Scholar 

  45. Casado, J. A. et al. A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research Network. J. Med. Genet. 44, 241–249 (2007)

    Article  CAS  Google Scholar 

  46. Gonzalez-Murillo, A., Lozano, M. L., Montini, E., Bueren, J. A. & Guenechea, G. Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors. Blood 112, 3138–3147 (2008)

    Article  CAS  Google Scholar 

  47. Bruun, D. et al. siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells. DNA Repair (Amst.) 2, 1007–1013 (2003)

    Article  CAS  Google Scholar 

  48. Nijman, S. M. et al. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 17, 331–339 (2005)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors are indebted to FA patients and their families for their cooperation. We are grateful to I. Badell, J. Couselo, A. Almeida and D. Schindler for collaboration in providing samples from FA patients, J.A. Casado for subtyping studies, M. Edel, J. Bilic, V. Pekarik and members of the laboratory for comments on the manuscript, J. M. Andrés-Vaquero for assistance with flow cytometry, R. Pujol for assistance with cytogenetics, M. J. Ramirez for immunofluorescence studies, B. Arán, M. Carrió and Y. Muñoz for assistance with cell culture techniques, E. Melo, L. Mulero and M. Martí for bioimaging assistance, and Y. Richaud, T. Lopez Rovira and M. L. Lozano for technical assistance. I.R.-P. and E.S. were recipients of pre-doctoral fellowships from MEC and DIUE, respectively. M.J.B. and G.T. were partially supported by the Ramón y Cajal program, and J.S. by the ICREA-Academia program. This work was partially supported by the Ministerio de Educación y Ciencia grants BFU2006-12251, SAF2005-00058, SAF2006-3440, and Genoma España (FANCOGENE), European Commission ‘Marie-Curie Reintegration Grant’ MIRG-CT-2007-046523 and European Program CONSERT LSHB-CT-2004-5242, the Fondo de Investigaciones Sanitarias (RETIC-RD06/0010/0016, PI061897, PI061099), Marató de TV3 (063430), the G. Harold and Leila Y. Mathers Charitable Foundation, Fundación Marcelino Botín, and Fundación Cellex.

Author information

Authors and Affiliations

  1. Center for Regenerative Medicine in Barcelona, Dr. Aiguader 88, 08003 Barcelona, Spain ,

    Ángel Raya, Ignasi Rodríguez-Pizà, Rita Vassena, María José Barrero, Antonella Consiglio, Eduard Sleep, Federico González, Gustavo Tiscornia, Elena Garreta, Trond Aasen, Anna Veiga & Juan Carlos Izpisúa Belmonte

  2. Institució Catalana de Recerca i Estudis Avançats (ICREA),,

    Ángel Raya

  3. Networking Center of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN),,

    Ángel Raya, Eduard Sleep, Elena Garreta & Trond Aasen

  4. Hematopoiesis and Gene Therapy Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Av. Complutense 22, 28040 Madrid, Spain,

    Guillermo Guenechea, Susana Navarro, Paula Río & Juan Bueren

  5. Networking Center of Biomedical Research in Rare Diseases (CIBERER),,

    Guillermo Guenechea, Susana Navarro, Maria Castellà, Paula Río, Jordi Surrallés & Juan Bueren

  6. Department of Biomedical Science and Biotechnology, University of Brescia, Viale Europa 11, 25123 Brescia, Italy,

    Antonella Consiglio

  7. Department of Genetics and Microbiology, Universitat Autonoma de Barcelona, 08193 Bellaterra, Spain

    Maria Castellà & Jordi Surrallés

  8. Laboratory of Genetics,,

    Inder M. Verma

  9. Gene Expression Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, California 92037, USA ,

    Juan Carlos Izpisúa Belmonte

Authors
  1. Ángel Raya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ignasi Rodríguez-Pizà
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guillermo Guenechea
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rita Vassena
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Susana Navarro
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. María José Barrero
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Antonella Consiglio
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Maria Castellà
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Paula Río
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Eduard Sleep
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Federico González
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Gustavo Tiscornia
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Elena Garreta
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Trond Aasen
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Anna Veiga
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Inder M. Verma
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Jordi Surrallés
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Juan Bueren
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Juan Carlos Izpisúa Belmonte
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Juan Carlos Izpisúa Belmonte.

Supplementary information

Supplementary Information

This file contains Supplementary Notes, Supplementary References, Supplementary Tables 1-2 and Supplementary Figures 1-12 with Legends. A missing line from the end of the Supplementary Notes was corrected on 08 October 2009. (PDF 3223 kb)

Supplementary Movie 1

This movie, which is in real-time, shows beating cardiomyocytes differentiated from cFA404-FiPS4F2 cells. (MOV 2312 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raya, Á., Rodríguez-Pizà, I., Guenechea, G. et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460, 53–59 (2009). https://doi.org/10.1038/nature08129

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature08129

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing